GPC2-CAR T cells tuned for low antigen density mediate potent

Por um escritor misterioso

Descrição

Pediatric cancers often mimic fetal tissues and express proteins normally silenced postnatally that could serve as immune targets. We developed T cell…
GPC2-CAR T cells tuned for low antigen density mediate potent
BiCisCAR T cells targeting both GPC2 and CD276 show potent NB
GPC2-CAR T cells tuned for low antigen density mediate potent
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity - ScienceDirect
GPC2-CAR T cells tuned for low antigen density mediate potent
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors. - Abstract - Europe PMC
GPC2-CAR T cells tuned for low antigen density mediate potent
Membrane Proteome Array (MPA), Antibody Specificity Profiling
GPC2-CAR T cells tuned for low antigen density mediate potent
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models, Journal of Experimental & Clinical Cancer Research
GPC2-CAR T cells tuned for low antigen density mediate potent
Strategies to enhance CAR-T persistence, Biomarker Research
GPC2-CAR T cells tuned for low antigen density mediate potent
PDF) Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
GPC2-CAR T cells tuned for low antigen density mediate potent
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma - ScienceDirect
GPC2-CAR T cells tuned for low antigen density mediate potent
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity - ScienceDirect
GPC2-CAR T cells tuned for low antigen density mediate potent
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation
GPC2-CAR T cells tuned for low antigen density mediate potent
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting
GPC2-CAR T cells tuned for low antigen density mediate potent
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
de por adulto (o preço varia de acordo com o tamanho do grupo)